Operating income increased 34.0%
Operating income changed +34.0% from the comparable as-filed period.
$265.0M→$355.2M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →HEI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income increased 32.8%
Net income changed +32.8% from the comparable as-filed period.
$177.3M→$235.4M3 prior comparisons
Operating margin moved 204 bp higher
Operating margin changed +204 basis points from the comparable as-filed period.
23.09%→25.14%3 prior comparisons
Revenue increased 23.1%
Revenue changed +23.1% from the comparable as-filed period.
$1.1B→$1.4B3 prior comparisons
Inventory / revenue moved 1172 bp lower
Inventory / revenue changed -1172 basis points from the comparable as-filed period.
114.19%→102.47%3 prior comparisons
Selling, general & administrative increased 17.5%
Selling, general & administrative changed +17.5% from the comparable as-filed period.
$192.1M→$225.8M3 prior comparisons
Research & development increased 13.1%
Research & development changed +13.1% from the comparable as-filed period.
$31.9M→$36.1M3 prior comparisons
Inventory increased 10.5%
Inventory changed +10.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.3B→$1.4B4 prior comparisons
Debt decreased 5.7%
Debt changed -5.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$3.7M→$3.5M4 prior comparisons
Cash & equivalents decreased 8.0%
Cash & equivalents changed -8.0% from the comparable as-filed period.
$261.9M→$241.0M2 prior comparisons
Debt decreased 10.2%
Debt changed -10.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$3.8M→$3.4M4 prior comparisons
Selling, general & administrative increased 15.5%
Selling, general & administrative changed +15.5% from the comparable as-filed period.
$189.7M→$219.1M3 prior comparisons
Inventory increased 13.3%
Inventory changed +13.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.2B→$1.4B4 prior comparisons
Cash & equivalents decreased 13.2%
Cash & equivalents changed -13.2% from the comparable as-filed period.
$242.3M→$210.3M2 prior comparisons
Revenue increased 25.3%
Revenue changed +25.3% from the comparable as-filed period.
$1.1B→$1.4B3 prior comparisons
Research & development increased 26.7%
Research & development changed +26.7% from the comparable as-filed period.
$28.7M→$36.4M3 prior comparisons
Operating margin moved 287 bp higher
Operating margin changed +287 basis points from the comparable as-filed period.
22.60%→25.47%3 prior comparisons
Operating income increased 41.2%
Operating income changed +41.2% from the comparable as-filed period.
$248.2M→$350.4M3 prior comparisons
Net income increased 49.1%
Net income changed +49.1% from the comparable as-filed period.
$156.8M→$233.8M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.